1. Acknowlegement

   Acknowledgments 17 September 2012 Pages: 975 - 977

2. Swimming Upstream

   • Jeremy A. Greene

   Commentary 17 September 2012 Pages: 979 - 982

3. Weighting Must Wait

   • Allan Wailoo
   • Aki Tsuchiya
   • Christopher McCabe

   Current Opinion 17 September 2012 Pages: 983 - 989

4. Cost Effectiveness of Herpes Zoster Vaccine in Canada

   • Mehdi Najafzadeh
   • Carlo A. Marra
   • David M. Patrick

   Original Research Article 17 September 2012 Pages: 991 - 1004

   

5. Willingness to Pay for a QALY Based on Community Member and Patient Preferences for Temporary Health States Associated with Herpes Zoster

   • Tracy A. Lieu
   • G. Thomas Ray
   • Donna Rusinak

   Original Research Article 17 September 2012 Pages: 1005 - 1016

   

6. Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials

   • Aline Gauthier
   • Andrea Manca
   • Susan Anton

   Original Research Article 17 September 2012 Pages: 1017 - 1029

   

7. Healthcare Costs and Obesity Prevention

   • David R. Rappange
   • Werner B. F. Brouwer
   • Pieter H. M. Van Baal

   Original Research Article 17 September 2012 Pages: 1031 - 1044

   

8. Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK

   • Jeroen P. Jansen
   • Ritesh Kumar
   • Yehuda Carmeli

   Original Research Article 17 September 2012 Pages: 1045 - 1056